Radiation after failed CAR t: tiny study ends early

NCT ID NCT04473937

First seen Nov 01, 2025 · Last updated Jun 19, 2026 · Updated 38 times

Summary

This pilot study tested whether radiation therapy could help people with lymphoma that did not respond to CAR T cell therapy. Only 3 participants were enrolled before the study was terminated early. The main goal was to check safety and side effects of adding radiation shortly after CAR T treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for REFRACTORY LYMPHOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Massachusetts General Hospital Cancer Center

    Boston, Massachusetts, 02114, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Radiotherapy

What this could lead to

If it works, this could point toward a way to improve outcomes for lymphoma patients who don't respond to CAR T cell therapy.

What could go wrong

This was a very small pilot study (only 3 participants) that was terminated early, so results are limited. It's unclear if radiation therapy is safe or effective in this setting.

Conditions

The condition(s) this trial relates to.

diffuse large B-cell lymphoma hematopoietic and lymphoid cell neoplasm hematopoietic and lymphoid system neoplasm high grade B-cell lymphoma lymphoma primary mediastinal large B-cell lymphoma relapsed/refractory diffuse large B-cell lymphoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.